Cure2Children and Sankalp India Foundation at the 2025 Annual Meeting of the American Society of Hematology

Sankalp India Foundation and Cure2Children marked a significant milestone with its participation in the 2025 Annual Meeting of the American Society of Hematology (ASH), one of the world’s foremost gatherings for experts in blood disorders. Representing India’s growing leadership in hematology and transfusion services, the foundation showcased its impactful work in improving access to safe blood, advancing care for hemoglobinopathies, and strengthening prevention programs. During the meeting, Sankalp highlighted data from its nationwide thalassemia management programs, underscoring improvements in patient outcomes through standardized clinical protocols, capacity-building initiatives, and collaborations with government and medical institutions. The foundation’s representatives engaged in discussions on strategies for prevention and equitable care for patients in low- and middle- income countries. Targeted antenatal screening and prevention of hemoglobinopathies inindia: Outcomes from a multi-state implementation of the sankalp model Optimizing outcomes and accessibility of matched sibling donor transplantation for severe hemoglobinopathies in low-resource settings.